Treatment options for streptococcal pharyngitis

Clinical Pediatrics

Volumn 46, Issue 4 SUPPL., 2007, Pages

  Marcy, S Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cephalosporins; Macrolides; Penicillins; Streptococcal pharyngitis

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFACLOR; CEFADROXIL; CEFALEXIN; CEFDINIR; CEFIXIME; CEFPODOXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTIBUTEN; CEFUROXIME; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; ERYTHROMYCIN; ERYTHROMYCIN ESTOLATE; MACROLIDE; PENICILLIN G; PENICILLIN V; PENICILLIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CHILD; CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HUMAN; PATIENT COMPLIANCE; PHARYNGITIS; PRACTICE GUIDELINE; PROPHYLAXIS; RECOMMENDED DRUG DOSE; REVIEW; RHEUMATIC FEVER; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE; ALTERNATIVE MEDICINE; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); GROUP A STREPTOCOCCAL INFECTION; META ANALYSIS (TOPIC); NONHUMAN; STREPTOCOCCAL PHARYNGITIS;

EID: 34247246316     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922807299720     Document Type: Review

References (70)

1. Gerber MA Diagnosis and treatment of pharyngitis in children. Pediatr Clin North Am. 2005 ; 52: 729-747.
2. Bisno AL Acute pharyngitis. N Engl J Med. 2001 ; 344: 205-211.
3. Hing E., Cherry DK, Woodwell DA National ambulatory medical care survey: 2003 summary. Adv Data. 2005 ; 365: 1-48.
4. Colletti T., Robinson P. Strep throat: guidelines for diagnosis and treatment. JAAPA. 2005 ; 18: 38-44.
5. Vincent MT, Celestin N., Hussain AN Pharyngitis. Am Fam Physician. 2004 ; 69: 1465-1470.
6. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 2002 ; 35: 113-125.
7. Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med. 2001 ; 34: 509-517.
8. Dajani A., Taubert K., Ferrieri P., Peter G., Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Pediatrics. 1995 ; 96: 758-764.
9. Randolph MF, Gerber MA, DeMeo KK, Wright L. Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr. 1985 ; 106: 870-875.
10. Krober MS, Bass JW, Michels GN Streptococcal pharyngitis. Placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA. 1985 ; 253: 1271-1274.
11. Casey JR, Pichichero ME Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics. 2004 ; 113: 866-882.
12. Shulman ST Acute streptococcal pharyngitis in pediatric medicine. Current issues in diagnosis and management. Pediatr Drugs. 2003 ; 5 (suppl 1). 13-23.
13. Pichichero ME, Casey JR, Mayes T., et al. Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies. Pediatr Infect Dis J. 2000 ; 19: 917-923.
14. Kaplan EL, Johnson DR Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics. 2001 ; 108: 1180-1186.
15. Chan DS, Demers DM, Bass JW Antimicrobial liquid formulations: a blind taste comparison of three brands of penicillin VK and three brands of amoxicillin. Ann Pharmacother. 1996 ; 30: 130-132.
16. Amoxil [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 1996.
17. Shvartzman P., Tabenkin H., Rosentwaig A., Dolginov F. Treatment of streptococcal pharyngitis with amoxicillin once a day. BMJ. 1993 ; 306: 1170-1172.
18. Feder HM, Gerber MA, Randolph MF, Stelmach PS, Kaplan EL Once-daily therapy for streptococcal pharyngitis with amoxicillin. Pediatrics. 1999 ; 103: 47-51.
19. Clegg HW, Ryan AG, Dallas SD Treatment of streptococcal pharyngitis with once-daily compared with twice-daily amoxicillin: a noninferiority trial. Pediatr Infect Dis J. 2006 ; 25: 761-767.
20. Shulman ST, Gerber MA So what's wrong with penicillin for strep throat ? Pediatrics. 2004 ; 13: 1816-1819.
21. Shulman ST Evaluation of penicilins, cephalosporins, and macrolides for therapy of streptococcal pharnygitis. Pediatrics. 1996 ; 97: 955-959.
22. Jacobs MR Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatr Infect Dis J. 2003 ; 22 (suppl 8). S109 - S119.
23. Cunha BA Therapeutic implications of antibacterial resistance in community-acquired respiratory tract infections in children. Infection. 2004 ; 32: 98-108.
24. Kaplan EL, Johnson DR, Del Rosario MC, Horn DL Susceptibility of Group A β-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatr Infect Dis J. 1999 ; 18: 1069-1072.
25. Felmingham D., Feldman C., Hryniewicz W., et al. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect. 2002 ; 8 (suppl 2). 12-42.
26. Shulman ST, Gerber MA, Tanz RR, Markowitz M. Streptococcal pharyngitis: the case for penicillin therapy. Pediatr Infect Dis J. 1994 ; 13: 1-7.
27. Pichichero ME, Margolis PA A comparison of cephalosporins and penicillins in the treatment of group A β-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J. 1991 ; 10: 275-281.
28. Casey JR, Pichichero ME Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis. 2004 ; 38: 1526-1534.
29. Casey Jr, Pinchichero ME. Meta-analysis of short course antibiotic treatment for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 2005 ; 24: 909-917.
30. Pichichero ME, Casey JR, Comparison of European and United States cephalosporin versus penicillin treatment results of group A streptococcal tonsillopharyngitis. Eur Clin Microbiol Infect Dis. 2006 ; 25: 353-364.
31. Brook I. Antibacterial therapy for acute Group A streptococcal pharyngotonsillitis. Short-course versus traditional 10-day oral regimens. Pediatr Drugs. 2002 ; 4: 747-754.
32. Zithromax [package insert]. New York, NY: Pfizer Inc ; 2004.
33. Biaxin [package insert]. North Chicago, Ill: Abbott Laboratories ; 2006.
34. Tarlow MJ Macrolides in the management of streptococcal pharyngitis/tonsillitis. Pediatr Infect Dis J. 1997 ; 16: 444-448.
35. Levenstein JH Clarithrmycin versus penicillin in the treatment of streptococcal pharyngitis. J Antimicrob Chemother. 1991 ; 27 (suppl A): 67-74.
36. Stein GE, Christensen S., Mummaw N. Comparative study of clarithromycin and penicillin V in the treatment of streptococcal pharyngitis. Eur J Clin Microbiol Infect Dis. 1991 ; 10: 949-953.
37. Schrock CG Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis. J Fam Pract. 1992 ; 35: 622-626.
38. Still JG, Hubbard WC, Poole JM, Sheaffer CI, Chartrand S., Jacobs R. Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies. Pediatr Infect Dis J. 1993 ; 12 (suppl 3). S134 - S141.
39. Martin JM, Green M., Barbadora KA, Wald ER Erythromycin-resistant group A streptococci in school-children in Pittsburgh. N Engl J Med. 2002 ; 346: 1200-1206.
40. Tanz RR, Shulman ST, Shortridge VD, et al. Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin Infect Dis. 2004 ; 39: 1794-1801.
41. York MK, Gibbs L., Perdreau-Remington F., Brooks GF Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of Northern California. J Clin Microbiol. 1999 ; 37: 1727-1731.
42. Hasenbein ME, Warner JE, Lambert KG, Cole SE, Onderdonk AB, McAdam AJ Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area. J Clin Microbiol. 2004 ; 42: 1559-1563.
43. Desjardins M., Delgaty KL, Ramotar K., Seetaram C., Toye B. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. J Clin Microbiol. 2004 ; 242: 5620-5623.
44. Green M., Martin JM, Barbadora KA, Beall B., Wald ER Reemergence of macrolide resistance in pharyngeal isolates of group A streptococci in southwestern Pennsylvania. Antimicrob Agents Chemother. 2004 ; 48: 473-476.
45. Katz KC, McGeer AJ, Duncan CL, et al. Emergence of macrolide resistance in throat culture isolates of group A streptococci in Ontario, Canada, in 2001. Antimicrob Agents Chemother. 2003 ; 47: 2370-2372.
46. Schito GC, Georgopoulos A., Prieto J. Antibacterial activity of oral antibiotics against community-acquired respiratory pathogens from three European countries. J Antimicrob Chemother. 2002 ; 50: 7-11.
47. Prieto J., Calvo A., Gómez-Lus ML Antimicrobial resistance: a class effect? J Antimicrob Chemother. 2002 ; 50 (suppl 2). 7-12.
48. Gooch WM III, McLinn SE, Aronovitz GH, et al. Efficacy of cefuroxime axetil suspension compared with that of penicillin V suspension in children with group A streptococcal pharyngitis. Antimicrob Agents Chemother. 1993 ; 37: 159-163.
49. Milatovic D., Adam D., Hamilton H., Materman E. Cefprozil versus penicillin V in treatment of streptococcal tonsillopharyngitis. Antimicrob Agents Chemother. 1993 ; 37: 1620-1623.
50. Gooch WM III, Swenson E., Higbee MD, Cocchetto DM, Evans EC Cefuroxime axetil and penicillin V compared in the treatment of group A β-hemolytic streptococcal pharyngitis. Clin Ther. 1987 ; 9: 670-677.
51. Brook I., Aronovitz GH, Pichichero ME Open-label, parallel-group, multicenter, randomized study of cefprozil versus erythromycin in children with group A streptococcal pharyngitis/tonsillitis. Clin Ther. 2001 ; 23: 1889-1990.
52. Aujard Y., Boucot I., Brahimi N., Chiche D., Bingen E. Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A β-hemolytic streptococcal pharyngitis in children. Pediatr Infect Dis J. 1995 ; 14: 295-300.
53. Adam D., Scholz H., Helmerking M. Comparison of short-course (5-day) cefuroxime axetil with standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis. J Antimicrob Chemother. 2000 ; 45: 23-30.
54. Scholz H. Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. Chemotherapy. 2004 ; 50: 1-4.
55. Mehra S., van Moerkerke M., Welck J., et al. Short course therapy with cefuroxime axetil for group A streptococcal tonsillopharyngitis in children. Pediatr Infect Dis J. 1998 ; 17: 452-457.
56. Esposito S., Marchisio P., Bosis S., et al. Comparative efficacy and safety of 5-day cefaclor and 10-day amoxicillin treatment of group A streptococcal pharyngitis in children. Int J Antimicrob Agents. 2002 ; 20: 28-33.
57. Tack KJ, Hedrick JA, Rothstein E., Nemeth MA, Keyserling C., Pichichero ME A study of 5-day cefdinir treatment for streptococcal pharyngitis in children. Arch Pediatr Adolesc Med. 1997 ; 151: 45-49.
58. Tack KJ, Henry DC, Gooch WM, Brink DN, Keyserling CH Five-day cefdinir treatment for streptococcal pharyngitis. Antimicrob Agents Chemother. 1998 ; 42: 1073-1075.
59. Pichichero ME, Gooch WM, Rodriquez W., et al. Effective short-course treatment of acute group A β-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children. Arch Pediatr Adolesc Med. 1994 ; 148: 1053-1060.
60. Portier H., Chavanet P., Waldner-Combernoux A., et al. Five versus ten day treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin. Scand J Infect Dis. 1994 ; 26: 59-66.
61. Nemeth MA, Gooch WM III, Hedrick J., Slosberg E., Keyserling CH, Tack KJ Comparison of cefdinir and penicillin for the treatment of pediatric streptococcal pharyngitis. Clin Ther. 1999 ; 21: 1525-1532.
62. Nemeth MA, McCarty J., Gooch WM III, Henry D., Keyserling CH, Tack KJ Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Clin Ther. 1999 ; 21: 1873-1881.
63. Brook I. A pooled comparison of cefdinir and penicillin in the treatment of group A β-hemolytic streptococcal pharyngotonsillitis. Clin Ther. 2005 ; 27: 1266-1273.
64. Omnicef [package insert]. North Chicago, Ill: Abbott Laboratories ; 2005.
65. Vantin [package insert]. New York, NY: Pfizer Inc ; 2003.
66. Pichichero ME, Disney FA, Aronovitx GH, Tlapey WB, Green JL, Francis AB Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis. Antimicrob Agents Chemother. 1987 ; 31: 903-906.
67. Holas C., Chiu Y-L., Notario G., Kapral D. A pooled analysis of seven randomized crossover studies of the palatability of cefdinir oral suspension versus amoxicillin/clavulanate potassium, cefprozil, azithromycin, and amoxicillin in children aged 4 to 8 years, Clin Ther. 2005 ; 27: 1950-1960.
68. Ramgoolan A., Steele R. Formulations of antibiotics for children in primary care. Effects on compliance and efficacy. Pediatr Drugs. 2002 ; 4: 323-333.
69. Steele RW, Thomas MP, Begue RE Compliance issues related to the selection of antibiotic suspensions for children. Pediatr Infect Dis J. 2001 ; 20: 1-5.
70. Curtin-Wirt Cd, Casey Jr, Murray PC, et al. Efficacy of penicillin vs. amoxicillin in children with group A beta hemolytic streptococcal tonsillopharyngitis. Clin Pediatr (Phila). 2003 ; 42: 219-225.